December 10, 2021 -- New technologies make advancements in life science research possible, such as the development of drugs, therapeutics, and molecular diagnostics. They are critical to the study of genes, cells, and proteins and, ultimately, a deeper understanding of biological systems and disease mechanisms.
The Life Science Industry Awards (LSIAs) acknowledge innovative products that have been introduced over the past year that contribute to the progress of science. The LSIAs are selected by BioInformatics, a Science and Medicine Group company, which draws on its network of scientific experts and lab personnel to choose the winners.
This year's LSIA winners represent a cross section of major laboratory equipment and consumable providers. The solutions address many of the most prominent developments in the life sciences, including CRISPR, single-cell genomics, and protein analysis. These innovative products illustrate the success of commercialized technologies meeting scientists' evolving R&D needs.
"The companies we honor with these prestigious awards are innovators who enable academic, clinical, and pharma/biotech scientists to make new discoveries and diagnoses," Bill Kelly, president of BioInformatics and founder of The Science Advisory Board, said in a statement. "We're proud to have supported them as they seek to enable the discovery of new genes, new cellular mechanisms, new protein functions, and, ultimately, the discovery of new treatments that make lives better."
Most Innovative New Product: Cell Biology
Most Innovative New Product: Genomics
Most Innovative New Product: Protein Analysis